Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Cumulative proportion surviving of the 4 groups

From: Survival after chemotherapy and/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: a case-control study

Months Chemo-radiotherapy Chemotherapy Radiation Stent
6 60.60% 43.47% 58.33% 38.46%
12 39.39% 34.78% 25.00% 19.23%
18 30.30% 13.04% 08.33% 07.69%
24 24.24% 08.69% 0% 03.84%
30 10.60% 04.34%   01.92%
36 07.57% 02.17%   00.96%
42 06.06% 0%   0%
48 05.19%    
54 04.32%    
60 03.46%